Skip to main content

Lack Of Regulation Stunts Growth Of New York State's Legal CBD And Marijuana Industries

New York State is anxiously awaiting legalization of adult recreational marijuana and regulations for CBD in food and drink.

New York Gov. Andrew Cuomo speaks about the $175.5 billion state budget during a news conference in the Red Room at the state Capitol Sunday, March, 31, 2019, in Albany, N.Y. (AP Photo/Hans Pennink)

ASSOCIATED PRESS

Legalized marijuana won’t be in New York’s annual state budget, Gov. Andrew Cuomo announced Friday. Many expected it to be part of the budget that’s expected to be confirmed tomorrow.

The details will be negotiated before the session closes in June, Cuomo said.

The air was hopeful at the recent Women in Cannabis conference, where policy experts, writers, growers and potential growers cheered at discussions about the April 1 deadline. Experts said they expected some version of the proposal to move forward.

In this Feb. 14, 2019 photo, Colton Welch, a junior at the State University of New York at Morrisville, N.Y., tends hydroponic tomato plants which will provide students with data applicable to cannabis cultivation. The college’s new minor in cannabis studies is among a handful of new university programs aimed at preparing students for careers in marijuana and hemp industries. (AP Photo/Marry Esch)

ASSOCIATED PRESS

Passionate advocates like Mary Pryor, co-founder of Cannaclusive, and Kassandra Frederique, New York State Director of the Drug Policy Alliance, emphasized the need for equity programs in the legislation, ensuring women, POC and people who currently deal marijuana have access to business opportunities.

The CBD market in the U.S. could represent $16 billion by 2025, according to a recent report by Cowen. Still, the prominence of CBD in food and drink, and the crackdown of its use in cafes, bars and restaurants, has confused some consumers. CBD served in food and drink is still illegal, according to the FDA.

Meanwhile, topical CBD products have arrived in two major drugstore chains, CVS and Walgreens, both announced this month. Sephora, Ulta, Neiman Marcus and others already carry CBD products.

Lawmakers need to set standards for CBD products, so the industry can create better products, educate consumers and ease them into buying and using CBD properly.

The U.S. Hemp Authority Seal is a start, but doesn’t hit all the points of entry to the CBD market: from skincare to water to gummies to unregulated, low-quality CBD sold online and in bodegas.

CBD has become popular in Italy and Switzerland, but can have higher THC content, 0.6% in Italy, and 1% in Switzerland, respectively. In the U.S. a CBD product can contain 0.3% THC maximum to be considered legal.

Recently resigned FDA Commissioner Scott Gottlieb said it could be years before adequate regulations are in place for CBD food and drink. For now, Dr. Ned Sharpless, head of the National Cancer Institute, is acting FDA commissioner, which may become permanent.

Conscious marijuana and CBD consumers demand an inclusive industry that educates people on safe, effective dosing.

Conscious marijuana and CBD consumers demand an inclusive industry that educates people on safe, effective dosing. Let’s hope regulation makes its way to the forefront so marijuana and CBD can help heal more people in a natural, safe, non-addictive way.

Original Article Source: https://www.forbes.com/sites/bethkaiserman/2019/03/31/new-york-state-cbd-marijuana/

Comments

Post a Comment

Popular posts from this blog

New York City Adds More Exceptions To Pre-Employment Marijuana Testing Ban

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the subs
Post a Comment
Read more

Charlotte Figi The Girl Who Inspired A CBD Movement Has Died At Age 13

Charlotte had recently been hospitalized due to pneumonia, breathing problems and seizures. She was treated as a likely case of Covid-19, her mother, Paige Figi, said Wednesday, although she tested negative for the virus. “Charlotte is no longer suffering. She is seizure-free forever,” a family friend wrote on Paige Figi’s Facebook page, announcing Charlotte’s death. “Thank you so much for all of your love.” Charlotte became a symbol of the possibilities of CBD after CNN Chief Medical Correspondent Dr. Sanjay Gupta told her story in the documentary “Weed.” In the film, Charlotte was shown to be a playful child who was overcome by horrific seizures, which were quelled with Charlotte’s Web, a marijuana strain named in her honor. Charlotte had Dravet syndrome, a rare form of epilepsy which was not controlled by medication. The Stanley brothers, marijuana growers in Colorado, were crossbreeding a strain of marijuana high in CBD and low in THC, its psychoactive ingredient. After Charlo
Post a Comment
Read more

Virginia CBD Program Criticized As Multistate Medical Cannabis Operators Gain Edge

Seven companies are challenging a CBD licensing process in Virginia that resulted in multistate medical marijuana operators getting a majority of available licenses. The appeals called the process “wildly prejudicial.” Out of 51 applicants for five vertically integrated CBD and THC-A licenses, multistate operators received three, a situation that spurred the appeals, The Virginian-Pilot reported. Applicants filing the appeals complained the closed-meeting review process lacked fairness and transparency. One consultant to an applicant said the selections felt “predetermined.” The Virginia Board of Pharmacy reportedly sent information to the applicants in December explaining its selections, but some applicants weren’t satisfied. A board spokeswoman wrote in an email to the Pilot that the board “does not comment on pending litigation.” The five winning applicants , called “pharmaceutical processors,” have a year from winning the licenses to become operational. The multistate
Post a Comment
Read more